The T1D Exchange is a nonprofit organization dedicated to accelerating therapies and improving care for individuals with type 1 diabetes. The 2025 Learning Session has been generously sponsored by the Leona M. and Harry B. Helmsley Charitable Trust, Sanofi, Vertex Pharmaceuticals, Dexcom, Medtronic, and Novo Nordisk. Its Quality Improvement Collaborative (T1DX-QI) comprises a network of 62 adult and pediatric diabetes centers (Figure 1), which collectively care for more than 250 000 people with diabetes (PWD). The T1DX-QI harnesses real-world data from its centers to evaluate and improve the quality of care delivered nationally to PWD, and its annual T1DX-QI Learning Session highlights the depth and breadth of this work.
Click here to read all the 2025 Learning Session abstracts